Terkko Navigator / International Clinical Psychopharmacology

Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative review.

Challenges associated with treating and preventing antipsychotic-induced constipation: considerations and cautions when prescribing novel interventions.

Evaluation of long-acting injectable antipsychotics with the corresponding oral formulation in a cohort of patients with schizophrenia: a real-world study in Spain.

Plasma prolidase levels are high in schizophrenia but not in first-episode psychosis.

The effects of adding long-acting injectable antipsychotic drugs to clozapine on relapse and hospitalization in patients with treatment-resistant schizophrenia: a mirror-image retrospective study.

The importance of monitoring renal function and concomitant medication to avoid toxicity in patients taking lithium.

Cognitive impairment in patients diagnosed with tramadol dependence compared to healthy controls.

Creatine kinase levels in psychotic patients who use cannabinoids.

Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorder.

Managing dissociative symptoms following the use of esketamine nasal spray: a case report.

Bilateral pedal edema associated with lurasidone: a case report.

Management of anxiety disorders in children with attention-deficit hyperactivity disorder: a narrative review.

Challenges associated with treating and preventing antipsychotic-induced constipation: considerations and cautions when prescribing novel interventions.

Evaluation of long-acting injectable antipsychotics with the corresponding oral formulation in a cohort of patients with schizophrenia: a real-world study in Spain.

Plasma prolidase levels are high in schizophrenia but not in first-episode psychosis.

The effects of adding long-acting injectable antipsychotic drugs to clozapine on relapse and hospitalization in patients with treatment-resistant schizophrenia: a mirror-image retrospective study.

The importance of monitoring renal function and concomitant medication to avoid toxicity in patients taking lithium.

Cognitive impairment in patients diagnosed with tramadol dependence compared to healthy controls.

Creatine kinase levels in psychotic patients who use cannabinoids.

Beneficial effect of quetiapine monotherapy in patients with bipolar depression and comorbid obsessive-compulsive disorder.

Managing dissociative symptoms following the use of esketamine nasal spray: a case report.

Bilateral pedal edema associated with lurasidone: a case report.

Hallucinations: diagnosis, neurobiology and clinical management.

Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges.

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study.

Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study.

Clozapine utilization at the United States Veterans Health Administration: a descriptive report of prescribing patterns and patient characteristics among Operation Enduring Freedom/Operation Iraqi Freedom Veterans.

Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria change.

The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study.

Predictive factors of long-term follow-up in treatment of Korean alcoholics with naltrexone or acamprosate.

Hallucinations: diagnosis, neurobiology and clinical management.

Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges.

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study.

Effect of pimavanserin on anxious depression in patients with major depression and an inadequate response to previous therapy: secondary analysis of the clarity study.

Clozapine utilization at the United States Veterans Health Administration: a descriptive report of prescribing patterns and patient characteristics among Operation Enduring Freedom/Operation Iraqi Freedom Veterans.

Medication utilization among adult patients with attention-deficit/hyperactivity disorder after reimbursement criteria change.

The effectiveness of very slow switching to aripiprazole in schizophrenia patients with dopamine supersensitivity psychosis: a case series from an open study.

Predictive factors of long-term follow-up in treatment of Korean alcoholics with naltrexone or acamprosate.

Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment.

Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology.

5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control.

Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics.

Benzodiazepine exposure in subjects with incident Alzheimer's disease and related syndromes in France: a longitudinal study 2011-2017.

Patterns of pharmacological treatment of patients with migraine, tension-type headache, and cluster headache in a large group of patients in Colombia, 2019.

Eosinophilic pneumonia during treatment with clozapine: reports from a retrospective case series.

Genetics and major depressive disorder: clinical implications for disease risk, prognosis and treatment.

Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology.

5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control.

Predictors of 1-year rehospitalization in inpatients with bipolar I disorder treated with atypical antipsychotics.

Benzodiazepine exposure in subjects with incident Alzheimer's disease and related syndromes in France: a longitudinal study 2011-2017.